Ocular Therapeutix Inc. buy Chardan Capital
Start price
09.12.25
/
50%
€13.61
Target price
09.12.26
€18.03
Performance (%)
-30.48%
Price
22.01.26
€9.46
Summary
This prediction is currently active. Massive losses of -30.48% have been the result for the BUY prediction by Chardan_Capital. This prediction currently runs until 09.12.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | -2.634% | -2.634% |
| iShares Core DAX® | -1.673% | 2.237% |
| iShares Nasdaq 100 | -1.346% | 0.290% |
| iShares Nikkei 225® | -1.529% | 5.863% |
| iShares S&P 500 | -1.702% | 0.697% |
Comments by Chardan_Capital for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Stopped prediction by Chardan_Capital for Ocular Therapeutix Inc.
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.36
05.11.25
05.11.25
€18.27
05.11.26
05.11.26
1.09%
22.01.26
22.01.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.43
02.10.25
02.10.25
€17.89
02.10.26
02.10.26
0.38%
22.01.26
22.01.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€10.62
15.09.25
15.09.25
€17.90
15.09.26
15.09.26
-10.86%
22.01.26
22.01.26